Sino Biopharmaceutic (SBMFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 06-2021 | 03-2021 | 09-2020 | 06-2020 | |
| Sales | 0 | 0 | 1,117,594 | 0 | 0 |
| Cost of Goods | N/A | N/A | 218,444 | N/A | N/A |
| Gross Profit | N/A | N/A | 899,150 | N/A | N/A |
| Operating Expenses | 0 | 0 | 677,935 | 0 | 0 |
| Operating Income | N/A | N/A | 221,660 | N/A | N/A |
| Interest Expense | 0 | 0 | 11,058 | 0 | 0 |
| Other Income | 0 | 0 | 227,819 | 0 | 0 |
| Pre-tax Income | 0 | 0 | 438,421 | 0 | 0 |
| Income Tax | N/A | N/A | 68,963 | N/A | N/A |
| Net Income Continuous | N/A | N/A | 369,458 | N/A | N/A |
| Minority Interests | N/A | N/A | 74,205 | N/A | N/A |
| Net Income | $N/A | $N/A | $295,253 | $N/A | $N/A |
| EPS Basic Total Ops | N/A | N/A | 0.02 | N/A | N/A |
| EPS Basic Continuous Ops | N/A | N/A | 0.02 | N/A | N/A |
| EPS Diluted Total Ops | N/A | N/A | 0.01 | N/A | N/A |
| EPS Diluted Continuous Ops | N/A | N/A | 0.02 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | 0.01 | N/A | 0.01 | N/A | N/A |
| EBITDA(a) | $N/A | $N/A | $221,660 | $N/A | $N/A |